NASDAQ

Cognition Therapeutics, Inc. (CGTX)

♥ 514 Thanks from members

Live price chart, market sentiment, and community perspectives for Cognition Therapeutics, Inc. (NASDAQ: CGTX).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Cognition Therapeutics Research TeamLeadership: Lisa Ricciardi (President and CEO)Leadership: Dr. Anthony Caggiano (Chief Medical Officer)Holder: Institutional Healthcare FundsHolder: InsidersCT1812SIGMAR1 Modulators#CGTX#Cognition Therapeutics#Neurodegeneration#Biotech Stock#NASDAQ CGTX